DYN
Dyne Therapeutics, Inc. · Healthcare
Director Jason P Rhodes sold $26K of Dyne Therapeutics, Inc.
Sold$25,884
$33.10Price
782Shares
What DYN did after the filing
- The stock from Tue, Nov 19 open, $28.89
- −14.3%
- S&P 500, same days
- +1.6%
Measured over 30 trading days, to the Jan 3 close.
Traded Thu, Nov 14. Filed Mon, Nov 18, 5:31 PM ET, after the close. Returns use the Nov 19 open and the Jan 3 close. Not investment advice.